Debarun Patra
Ropar, PB, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 04, 2025
Macrophage foam cell-derived mediator promotes spontaneous fat lipolysis in atherosclerosis models.
Journal: Journal of leukocyte biology
Published: July 28, 2024
Adipose tissue macrophage-derived microRNA-210-3p disrupts systemic insulin sensitivity by silencing GLUT4 in obesity.
Journal: The Journal of biological chemistry
Published: January 27, 2024
Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes.
Journal: Frontiers in molecular biosciences
Published: May 18, 2023
Anti-cancer drug molecules targeting cancer cell cycle and proliferation.
Journal: Advances in protein chemistry and structural biology
Published: April 15, 2023
Pharmacological inhibition of DNMT1 restores macrophage autophagy and M2 polarization in Western diet-induced nonalcoholic fatty liver disease.
Journal: The Journal of biological chemistry
Published: December 09, 2022
A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation in-vitro and in-vivo.
Journal: European journal of pharmacology
Published: November 15, 2022
miR-210-3p Promotes Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Targeting SOCS1-Mediated NF-κB Pathway.
Journal: Diabetes
Published: March 31, 2022
Lipid-induced monokine cyclophilin-A promotes adipose tissue dysfunction implementing insulin resistance and type 2 diabetes in zebrafish and mice models of obesity.
Journal: Cellular and molecular life sciences : CMLS
Published: January 21, 2022
Last Updated: 09/26/2026